MA
MIRM icon

MCF Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

MCF Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.3K Buy
515
+53
+11% +$5.32K ﹤0.01% 643
2026
Q1 		$42.7K Buy
462
+26
+6% +$2.45K ﹤0.01% 635
2025
Q4 		$34.4K Buy
436
+9
+2% +$646 ﹤0.01% 579
2025
Q3 		$31.3K Buy
427
+185
+76% +$11.8K ﹤0.01% 494
2025
Q2 		$12.3K Hold
242
– – ﹤0.01% 618
2025
Q1 		$10.9K Buy
242
+39
+19% +$1.84K ﹤0.01% 639
2024
Q4 		$8.39K Hold
203
– – ﹤0.01% 689
2024
Q3 		$7.92K Buy
+203
New +$8.1K ﹤0.01% 686

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCF Advisors's MIRM Position: Q2 2026 in Review

MCF Advisors increased its Mirum Pharmaceuticals (MIRM) stake by 11% in Q2 2026, buying an estimated $5.32K and bringing the position to 515 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #643.

MCF Advisors first reported a position in MIRM in Q3 2024 and has held it in 8 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • MCF Advisors held 515 shares of Mirum Pharmaceuticals worth $60.3K as of Q2 2026.
  • MCF Advisors bought 53 Mirum Pharmaceuticals shares in Q2 2026, an estimated $5.32K.
  • Mirum Pharmaceuticals made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #643 holding.
  • MCF Advisors first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.